Endothelial dysfunction and type 2 diabetes
暂无分享,去创建一个
[1] G. D. Johnston,et al. Impaired endothelium-dependent and independent vasodilation in patients with Type 2 (non-insulin-dependent) diabetes mellitus , 1992, Diabetologia.
[2] S. Jackson,et al. The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. , 2001, Atherosclerosis.
[3] L. Lerman,et al. Simvastatin Preserves Coronary Endothelial Function in Hypercholesterolemia in the Absence of Lipid Lowering , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[4] C. Dessy,et al. Hydroxy-Methylglutaryl–Coenzyme A Reductase Inhibition Promotes Endothelial Nitric Oxide Synthase Activation Through a Decrease in Caveolin Abundance , 2001, Circulation.
[5] L. Title,et al. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. , 2000, Journal of the American College of Cardiology.
[6] S. Homma,et al. Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[7] L. Rodríguez-Mañas,et al. Treatment with acarbose may improve endothelial dysfunction in streptozotocin-induced diabetic rats. , 2000, Journal of cardiovascular pharmacology.
[8] S. Jackson,et al. Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. , 2000, Circulation.
[9] J. Jukema,et al. Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[10] G. Schuler,et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. , 2000, The New England journal of medicine.
[11] P. Groop,et al. In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. , 1999, Diabetes care.
[12] F. Logerfo,et al. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. , 1999, Diabetes care.
[13] H. Bohlen,et al. Acute hyperglycemia depresses arteriolar NO formation in skeletal muscle. , 1999, American journal of physiology. Heart and circulatory physiology.
[14] W. Sheu,et al. Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia. , 1999, Diabetes care.
[15] M. Carrier,et al. Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy , 1999, Diabetes/metabolism research and reviews.
[16] J. Cockcroft,et al. Effect of oral vitamin E (α‐tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[17] D. Rader,et al. A novel endothelial-derived lipase that modulates HDL metabolism , 1999, Nature Genetics.
[18] M. Carrier,et al. Pharmacology: Pharmacological Modulation of Endothelial Function by Insulin in the Rat Aorta , 1998, The Journal of pharmacy and pharmacology.
[19] K. Kugiyama,et al. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. , 1998, Atherosclerosis.
[20] N. Benda,et al. Preserved Endothelial Function in IDDM Patients, but Not in NIDDM Patients, Compared With Healthy Subjects , 1998, Diabetes Care.
[21] G. Plotnick,et al. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. , 1997, JAMA.
[22] A. Heagerty,et al. Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study. , 1997, Circulation.
[23] A. Quyyumi,et al. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. , 1997, Circulation.
[24] D. Playford,et al. Low‐density lipoprotein size, high‐density lipoprotein concentration, and endothelial dysfunction in non‐insulin‐dependent diabetes , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[25] A. Bist,et al. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[26] S. Coppack,et al. Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome , 1997, Diabetes.
[27] A. Baron,et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. , 1997, The Journal of clinical investigation.
[28] B. Williams,et al. Factors regulating the expression of vascular permeability/vascular endothelial growth factor by human vascular tissues , 1997, Diabetologia.
[29] C. Cobelli,et al. Forearm Nitric Oxide Balance, Vascular Relaxation, and Glucose Metabolism in NIDDM Patients , 1997, Diabetes.
[30] H. Maegawa,et al. Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells , 1997, Diabetologia.
[31] A. Zeiher,et al. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. , 1997, Circulation.
[32] G. Watts,et al. Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity. , 1997, Journal of the American College of Cardiology.
[33] N. Hoogerbrugge,et al. Hypertriglyceridemia Enhances Monocyte Binding to Endothelial Cells in NIDDM , 1996, Diabetes Care.
[34] R. Marfella,et al. Metformin Improves Hemodynamic and Rheological Responses to L-Arginine in NIDDM Patients , 1996, Diabetes Care.
[35] T. Lüscher,et al. Lipids and endothelial function: effects of lipid-lowering and other therapeutic interventions , 1996, Current opinion in lipidology.
[36] H. Hobbs,et al. Expression of the VLDL receptor in endothelial cells. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[37] M. Creager,et al. -.____----.---_-Impaired Nitric Oxide-Mediated Vasodilation in Patients With Non-Insulin-Dependent Diabetes Mellitw , 2016 .
[38] Farris K. Timimi,et al. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. , 1996, The Journal of clinical investigation.
[39] B. Egan,et al. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. , 1995, Hypertension.
[40] W. Weintraub,et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. , 1995, The New England journal of medicine.
[41] A. Baron,et al. Hemodynamic actions of insulin. , 1994, The American journal of physiology.
[42] B. Tesfamariam. Free radicals in diabetic endothelial cell dysfunction. , 1994, Free radical biology & medicine.
[43] S. Lillioja,et al. Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men. , 1994, The Journal of clinical investigation.
[44] E. Levin,et al. Insulin Stimulates Production and Secretion of Endothelin From Bovine Endothelial Cells , 1993, Diabetes.
[45] R. Cohen,et al. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. , 1992, The American journal of physiology.
[46] T. Lüscher,et al. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. , 1992, Circulation research.
[47] B. Hoffman,et al. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. , 1992, The Journal of clinical investigation.
[48] R. Cohen,et al. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. , 1991, The Journal of clinical investigation.
[49] K. Tracey,et al. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.
[50] L. Edvinsson,et al. Vasomotor changes in isolated coronary arteries from diabetic rats. , 1988, Acta physiologica Scandinavica.